866588-01-4 Usage
Uses
Used in Pharmaceutical Industry:
4-[(3-methyl-5-phenyl-1H-pyrazol-1-yl)methyl]phenylmethanol is used as a building block for the synthesis of various medicinal drugs. Its unique structure allows it to be a valuable component in the development of new pharmaceuticals.
Used in Organic Synthesis:
4-[(3-methyl-5-phenyl-1H-pyrazol-1-yl)methyl]phenylmethanol is also utilized in organic synthesis, where it can serve as a reagent in chemical reactions to produce a range of different products.
Used in Anticancer Research:
4-[(3-methyl-5-phenyl-1H-pyrazol-1-yl)methyl]phenylmethanol has been studied for its potential anticancer properties, making it a candidate for further research and development in the field of oncology.
Used in Anti-inflammatory Applications:
4-[(3-methyl-5-phenyl-1H-pyrazol-1-yl)methyl]phenylmethanol has shown potential anti-inflammatory properties, which could make it useful in the development of treatments for various inflammatory conditions.
Used in Antimicrobial Applications:
Additionally, 4-[(3-methyl-5-phenyl-1H-pyrazol-1-yl)methyl]phenylmethanol has demonstrated antimicrobial properties, suggesting its potential use in the development of new antibiotics or antifungal agents.
Check Digit Verification of cas no
The CAS Registry Mumber 866588-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,5,8 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 866588-01:
(8*8)+(7*6)+(6*6)+(5*5)+(4*8)+(3*8)+(2*0)+(1*1)=224
224 % 10 = 4
So 866588-01-4 is a valid CAS Registry Number.
866588-01-4Relevant academic research and scientific papers
ALKOXYPHENYLPROPANOIC ACID DERIVATIVES
-
Page/Page column 41, (2008/06/13)
The present invention aims at provision of a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. The compound represented by the formula: wherein each symbol is as defined in the description, a salt thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonistic activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents as agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
